Bone morphogenetic protein-2 enhances bone regeneration mediated by transplantation of osteogenically undifferentiated bone marrow-derived mesenchymal stem cells

Biotechnology Letters

Volumn 30, Issue 7, 2008, Pages 1163-1168

  Kang, Sun Woong ^a   La, Wan Geun ^a   Kang, Jin Muk ^a   Park, Jung Ho ^b   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

^b Korea University   (South Korea)

Author keywords

Bone marrow derived stem cell; Bone morphogenetic protein 2; Bone regeneration; Tissue engineering

Indexed keywords

BONE MARROW-DERIVED STEM CELL; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION;

CELLS; PROTEINS; TISSUE ENGINEERING;

BONE;

BIOMATERIAL; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; FIBRINOLYTIC AGENT; HEPARIN; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HUMAN; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED;

BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CELL DIFFERENTIATION; CELLS, CULTURED; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; LACTIC ACID; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOGENESIS; POLYGLYCOLIC ACID; TRANSFORMING GROWTH FACTOR BETA;

EID: 44949119587     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-008-9675-8     Document Type: Article

References (20)

1. Cheng SL, Yang JW, Rifas L et al (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286
2. Flautre B, Anselme K, Delecourt C et al (1999) Histological aspects in bone regeneration of an association with porous hydroxyapatite and bone marrow cells. J Mater Sci Mater Med 10:811-814
3. Fromigue O, Marie PJ, Lomri A (1998) Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68:411-426
4. Haynesworth SE, Goshima J, Goldberg VM et al (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88
5. Huang W, Carlsen B, Wulur I et al (2004) BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp Cell Res 299:325-334
6. Ito C, Evans WE, McNinch L et al (1996) Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 14:2370-2376
7. Jaiswal N, Haynesworth SE, Caplan AI et al (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312
8. Jeon O, Song SJ, Kang SW et al (2007) Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 28:2763-2771
9. Malaval L, Modrowski D, Gupta AK et al (1994) Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158:555-572
10. Niemeyer P, Krause U, Fellenberg J et al (2004) Evaluation of mineralized collagen and alpha-tricalcium phosphate as scaffolds for tissue engineering of bone using human mesenchymal stem cells. Cells Tissues Organs 177:68-78
11. Owen TA, Aronow M, Shalhoub V et al (1990) Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430
12. Park MS, Kim SS, Cho SW et al (2006) Enhancement of the osteogenic efficacy of osteoblast transplantation by the sustained delivery of basic fibroblast growth factor. J Biomed Mater Res B 79:353-359
13. Petite H, Viateau V, Bensaid W et al (2000) Tissue-engineered bone regeneration. Nat Biotechnol 18:959-963
14. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
15. Quarto R, Mastrogiacomo M, Cancedda R et al (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385-386
16. Song SJ, Jeon O, Yang HS et al (2007) The effects of culture conditions on osteogenic differentiation in human mesenchymal stem cells. J Microbiol Biotechnol 17:1113-1119
17. Sun JS, Chang WHS, Chen LT et al (2004) The influence on gene-expression profiling of osteoblasts behavior following treatment with the ionic products of sintered b-dicalcium pyrophosphate dissolution. Biomaterials 25:607-616
18. van den Dolder J, Farber E, Spauwen PH et al (2003) Bone tissue reconstruction using titanium fiber mesh combined with rat bone marrow stromal cells. Biomaterials 24:1745-1750
19. Yamamoto M, Takahashi Y, Tabata Y (2003) Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24:4375-4383
20. Yoshikawa T, Ohgushi H, Akahane M et al (1998) Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites: a comparison with the osteogenic ability of cancellous bone. J Biomed Mater Res 41:568-573